Literature DB >> 35199540

The effect of obesity, hypertension, diabetes mellitus, alcohol, and sleep apnea on the risk of atrial fibrillation.

Z Čarná1, P Osmančík.   

Abstract

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia associated with a two-fold increase in mortality caused by a higher risk of stroke and heart failure. Currently, AF is present in ~ 2 % of the general population, and its incidence and prevalence are increasing. Obesity, hypertension, diabetes mellitus, obstructive sleep apnea, and alcohol consumption increase the risk of AF. Each unit of increase in BMI increases the risk of AF by 3 %, and intensive weight loss is also associated with reduced AF recurrence. Hypertension increases the risk of AF by 50 % in men and by 40 % in women, and explains ~ 20 % of new AF cases. Patients with obstructive sleep apnea are at four times higher risk of developing AF than subjects without sleep apnea. Higher concentrations of pro-inflammatory cytokines, higher amounts of epicardial adipose tissue, and a higher degree of ventricular diffuse myocardial fibrosis are present in AF patients and patients with the aforementioned metabolic disorders. Several prospective cohort studies and randomized trials have been initiated to show whether weight loss and treatment of other risk factors will be associated with a reduction in AF recurrences.

Entities:  

Mesh:

Year:  2021        PMID: 35199540      PMCID: PMC9054178          DOI: 10.33549/physiolres.934744

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   2.139


  94 in total

1.  Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.

Authors:  Ali H Mokdad; Earl S Ford; Barbara A Bowman; William H Dietz; Frank Vinicor; Virginia S Bales; James S Marks
Journal:  JAMA       Date:  2003-01-01       Impact factor: 56.272

2.  Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation.

Authors:  Apoor S Gami; Dave O Hodge; Regina M Herges; Eric J Olson; Jiri Nykodym; Tomas Kara; Virend K Somers
Journal:  J Am Coll Cardiol       Date:  2007-01-22       Impact factor: 24.094

3.  Gadolinium decreases stretch-induced vulnerability to atrial fibrillation.

Authors:  F Bode; A Katchman; R L Woosley; M R Franz
Journal:  Circulation       Date:  2000-05-09       Impact factor: 29.690

4.  Magnetic Resonance Imaging-Guided Fibrosis Ablation for the Treatment of Atrial Fibrillation: The ALICIA Trial.

Authors:  Felipe Bisbal; Eva Benito; Albert Teis; Francisco Alarcón; Axel Sarrias; Gala Caixal; Roger Villuendas; Paz Garre; Nina Soto; Jennifer Cozzari; Eduard Guasch; Gladys Juncà; Susanna Prat-Gonzalez; Rosario J Perea; Victor Bazán; José María Tolosana; Elena Arbelo; Antoni Bayés-Genís; Lluis Mont
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-10-08

5.  Diabetes mellitus, glycemic control, and risk of atrial fibrillation.

Authors:  Sascha Dublin; Nicole L Glazer; Nicholas L Smith; Bruce M Psaty; Thomas Lumley; Kerri L Wiggins; Richard L Page; Susan R Heckbert
Journal:  J Gen Intern Med       Date:  2010-04-20       Impact factor: 5.128

6.  Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy.

Authors:  Darcy M Putz; Whitney S Goldner; Robert S Bar; William G Haynes; William I Sivitz
Journal:  Metabolism       Date:  2004-11       Impact factor: 8.694

7.  The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts.

Authors:  Domenico Corradi; Roberta Maestri; Sergio Callegari; Paolo Pastori; Matteo Goldoni; Tu Vinh Luong; Cesare Bordi
Journal:  Cardiovasc Pathol       Date:  2004 Nov-Dec       Impact factor: 2.185

8.  Relation of Pericardial Fat, Intrathoracic Fat, and Abdominal Visceral Fat With Incident Atrial Fibrillation (from the Framingham Heart Study).

Authors:  Jane J Lee; Xiaoyan Yin; Udo Hoffmann; Caroline S Fox; Emelia J Benjamin
Journal:  Am J Cardiol       Date:  2016-08-24       Impact factor: 2.778

9.  Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study.

Authors:  Guido A Rosito; Joseph M Massaro; Udo Hoffmann; Frederick L Ruberg; Amir A Mahabadi; Ramachandran S Vasan; Christopher J O'Donnell; Caroline S Fox
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

Review 10.  Inflammation in atrial fibrillation.

Authors:  Yutao Guo; Gregory Y H Lip; Stavros Apostolakis
Journal:  J Am Coll Cardiol       Date:  2012-12-04       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.